IP Library Granted Patent US 10,942,170
Granted Patent B2
US 10,942,170 · App. 14/664,481 · Granted Mar 9, 2021

Quantitative measurement of human blastocyst and morula morphology developmental kinetics

Inventors: Lei Tan (Menlo Park, CA); Martin Chian (Menlo Park, CA); Alice Chen Kim (Menlo Park, CA); Peter Lorenzen (Menlo Park, CA)
Assignee: Ares Trading S.A.
G01N33/5091C12N5/0604G01N15/1463G01N33/4833G06K9/00147G06T7/0016G01N2015/1493G01N2015/1497G06T2207/10056G06T2207/30044
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,942,170
App. No.
14/664,481
Granted
Mar 9, 2021
Kind
B2
Abstract

Methods, compositions and kits for determining the developmental potential of one or more embryos are provided. These methods, compositions and kits find use in identifying embryos in vitro that are most useful in treating infertility in humans.

Claims (19)

1. A method for treating infertility, comprising:

a) providing a computer system comprising:

i) a time-lapse microscope comprising a camera and software for automatically acquiring a series of time-sequential images of one or more human embryos contained in a multi-well culture dish comprising a plurality of microwells with a camera of at least one time-lapse microscope, wherein said one or more human embryos are between about three (3)-five (5) days following fertilization; and

ii) a computer in communication with said microscope, said computer comprising image analysis software;

b) extracting one or more image features from said series of time-sequential images with said image analysis software, wherein said one or more image features comprise a plurality of cell parameters wherein at least one of said plurality of cell parameters is selected from the group consisting of a time from first cleavage to cavitation (tCav) parameter and an average size after initial expansion (Pexp-area) parameter;

c) classifying said one or more human embryos as: i) euploid when said Pexp-area parameter is within 21.25-20.75 k pixels or when said tCav parameter is within 72.65-71.95 hours; or ii) aneuploid when said Pexp-area parameter is within 19.67-16.33 k pixels or when said tCav parameter is within 74.97-73.83 hours;

d) selecting a euploid human embryo based on said classifying; and

e) treating a recipient with in vitro fertilization by single embryo transfer of said selected human embryo.

2. The method of claim 1 wherein said image features include at least one of: cell boundary segment distribution, average intensity at embryo center, or standard deviation of intensity at embryo center.

3. The method of claim 1 further comprising determining a parameter from said image features, wherein said parameter identifies one of:

duration of expansion, duration of collapse, frequency of collapse, degree of expansion, degree of collapse, rate of expansion, rate of collapse, average embryo size after initial expansion and the time interval between expansion and collapse.

4. The method of claim 1 wherein said one or more human embryos have not been frozen.

5. The method of claim 1 wherein said one or more human embryos have been frozen.

6. The method of claim 1 , wherein said image feature is selected from the group consisting of embryo shape, texture in the region defined around the embryo edge, and texture at embryo center.

7. The method of claim 6 , wherein said extracting of said image features is selected from the group consisting of a shape based method, a low level method, a curvature based method and a combination thereof.

8. The method of claim 7 , wherein said shape based method is at least one of template matching, Hough transforms or a combination thereof.

9. The method of claim 1 , wherein said classifying uses a classifier selected from the group consisting of a nave Bayesian classifier, a SVM classifier, a Random Forest classifier and a Boosting Tree classifier.

10. The method of claim 1 , wherein said selected human embryo is euploid and viable.

11. The method of claim 1 , wherein said selecting comprises physically moving said selected human embryo from one location to another.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2018
From: PROGYNY, INC.
To: ARES TRADING S.A.
Reel/Frame 047419/0728 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2015
From: TAN, LEI; CHIAN, MARTIN; KIM, ALICE CHEN; LORENZEN, PETER
To: AUXOGYN, INC.
Reel/Frame 036995/0736 →
CHANGE OF NAME Recorded Jul 21, 2015
From: AUXOGYN, INC.
To: PROGYNY, INC.
Reel/Frame 036148/0828 →
Continuity (2)
Provisional Application 61968260 · Mar 20, 2014
Related Publication 20150268227A1 · Sep 24, 2015
Cited By (8)
US 12,205,280 US 12,205,281 US 12,205,282 US 12,205,283 US 12,236,588 US 12,406,187 US 12,591,781 US 12,602,785